Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 4/20 | 0.79 |
| ▸ | GABBR1 | Q9UBS5 | 4/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.79 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.79 |
| ▸ | MEN1 | O00255 | 2/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.79 |
| ▸ | DRD3 | P35462 | 1/20 | 0.79 |
| ▸ | BLM | P54132 | 1/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.79 |
| ▸ | THRB | P10828 | 1/20 | 0.79 |
| ▸ | TSHR | P16473 | 1/20 | 0.79 |
| ▸ | FNTA | P49354 | 4/20 | 0.60 |
| ▸ | FNTB | P49356 | 4/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28014207 | 0.98 | GABBR2 (0.76) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL7822991 | 0.91 | GABBR2 (0.72) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL22172484 | 0.91 | GABBR2 (0.72) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL9076600 | 0.90 | GABBR2 (0.71) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL15405894 | 0.90 | GABBR2 (0.71) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL7525502 | 0.90 | GABBR2 (0.71) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL657723 | 0.89 | GABBR2 (0.65) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL10253260 | 0.89 | CYP2C9 (0.65) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL16249736 | 0.89 | GABBR2 (0.61) | GABBR2GABBR1CYP2C9LMNACYP2D6 | |
| SCHEMBL11321913 | 0.88 | GABBR2 (0.69) | GABBR2GABBR1CYP2C9LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113564144-B | Lipase mutant and application thereof | 上海奥博生物医药股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-115403778-B | Fluorescence enhanced coordination polymer for detecting erythromycin in water and application thereof | 渤海大学 | 2023-06-09 | — | — | CN | claimed |
| CN-115403778-A | Fluorescence-enhanced coordination polymer for detecting erythromycin in water and application thereof | 渤海大学 | 2022-11-29 | — | — | CN | claimed |
| CN-111118232-B | Retanning filler and preparation method thereof | 温州大学 | 2022-04-01 | — | — | CN | claimed |
| CN-113736066-A | Shape memory epoxy resin with adjustable recovery stress and recovery stress regulation and control method of shape memory epoxy resin | 中国工程物理研究院化工材料研究所 | 2021-12-03 | — | — | CN | claimed |
| CN-111118232-A | Retanning filler and preparation method thereof | 温州大学 | 2020-05-08 | — | — | CN | claimed |
| CN-110698338-A | Preparation method of 3- (4-chlorobenzene) glutaric acid | 广西奕安泰药业有限公司 | 2020-01-17 | — | — | CN | claimed |
| CN-109053425-A | A kind of high-purity 3-(4- chlorobenzene) glutaric acid purification preparation method | 中山奕安泰医药科技有限公司 | 2018-12-21 | — | — | CN | claimed |
| CN-104592007-B | A kind of 3-(4-chloro-phenyl-) pentanedioic acid cadmium coordination polymer and preparation method thereof | Suzhou College (CN) | 2016-03-30 | — | — | CN | claimed |
| CN-104592259-A | Zn (II) coordination polymer and preparation method thereof | UNIV SUZHOU | 2015-05-06 | — | — | CN | claimed |
| CN-104592007-A | 3-(4-chlorphenyl) glutaric acid cadmium coordination polymer and preparation method thereof | UNIV SUZHOU | 2015-05-06 | — | — | CN | claimed |
| CN-102863347-B | Preparation method of chiral baclofen | MENG KUN | 2015-01-14 | — | — | CN | claimed |
| CN-102863347-A | Preparation method of chiral baclofen | MENG KUN | 2013-01-09 | — | — | CN | claimed |
| CN-101514167-B | Preparation method of chiral baclofen | MENG KUN | 2012-11-28 | — | — | CN | claimed |
| CN-101514167-A | Preparation method of chiral baclofen | MENG KUN (CN) | 2009-08-26 | — | — | CN | claimed |
| US-20230312807-A1 | SPANDEX FIBER WITH REVERSIBLE TRIPLE-SHAPE MEMORY EFFECT AND PREPARATION METHOD THEREOF | WUYI UNIVERSITY (CN) | 2023-10-05 | — | — | US | disclosed |
| CN-115403778-B | Fluorescence enhanced coordination polymer for detecting erythromycin in water and application thereof | 渤海大学 | 2023-06-09 | — | — | CN | disclosed |
| US-20090149465-A1 | AMINOTETRALIN COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS | THERAVANCE BIOPHARMA R&D IP, LLC | 2009-06-11 | — | — | US | disclosed |
| EP-0518939-A1 | ANTIARRHYTHMIC AGENTS | BTG INTERNATIONAL LIMITED (GB) | 1992-12-23 | — | — | EP | disclosed |
| WO-1991013865-A1 | ANTIARRHYTHMIC AGENTS | ISIS INNOVATION LIMITED (GB) | 1991-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149465-A1 | AMINOTETRALIN COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS | OPRL1, OPRM1, OPRK1 | GABBR2 908/4885GABBR1 981/4885CYP2C9 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.